Boston Therapeutics, Inc.
Boston Therapeutics, Inc. (BTHE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BTHE · as of Jun 9, 2026
Key Statistics
Explore Boston Therapeutics, Inc. Data
bthe stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
bthe competitorsBTHE
AVEFF
BNOEF
FLWPF
FWPAY
HBCNFStock Performance
Full HistoryAbout Boston Therapeutics, Inc.
Boston Therapeutics, Inc. Founded in 2009 and headquartered in Lawrence, Massachusetts, Boston Therapeutics, Inc. operates as a pre-clinical and clinical-stage pharmaceutical development firm. The company specializes in the de…
what is boston therapeutics, inc. · bthe stock overview · boston therapeutics, inc. company profile · who is boston therapeutics, inc. ceo · bthe OTC · boston therapeutics, inc. headquarters · boston therapeutics, inc. business segments
About Stock Overview & Key Data
Boston Therapeutics, Inc. (BTHE) is a Healthcare company in the Biotechnology industry, listed on OTC since Mar 20, 2012. As of the latest trading session, BTHE stock price is $0.01, with a market capitalization of $0. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2020, Boston Therapeutics, Inc. reported revenue of $9336.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Boston Therapeutics, Inc. (BTHE) stock price is $0.01. The stock is traded on OTC under the ticker symbol BTHE. The 52-week range is $0.01 – $0.01.